.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Medtronic
Cipla
Novartis
Baxter
Mallinckrodt
Argus Health
Harvard Business School
Johnson and Johnson

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202795

« Back to Dashboard
NDA 202795 describes NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, which is a drug marketed by Altaire Pharms Inc and Akorn Inc and is included in two NDAs. It is available from five suppliers. Additional details are available on the NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE profile page.

The generic ingredient in NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE is naphazoline hydrochloride; pheniramine maleate. There are six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.

Summary for 202795

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202795

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC 202795 ANDA Walgreens 0363-9650 0363-9650-02 1 BOTTLE, DROPPER in 1 CARTON (0363-9650-02) > 15 mL in 1 BOTTLE, DROPPER
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC 202795 ANDA Akorn, Inc. 17478-065 17478-065-12 1 BOTTLE, DROPPER in 1 CARTON (17478-065-12) > 15 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION/DROPS;OPHTHALMICStrength0.025%;0.3%
Approval Date:Jan 24, 2013TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Julphar
Accenture
Medtronic
Queensland Health
Chubb
Harvard Business School
Johnson and Johnson
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot